Illumina-Backed Cancer Screening Co. To Raise Over $1B
DNA analysis company Illumina Inc. said that a cancer screening company it created recently is looking to raise north of $1 billion in its second round of major financing, according to...To view the full article, register now.
Already a subscriber? Click here to view full article